GSK, Thalidomide Plaintiffs Spar Over Pa., Federal Jurisdiction

Law360, Philadelphia (March 5, 2013, 5:29 PM EST) -- Two people born with birth defects allegedly caused by the morning-sickness drug thalidomide squared off with GlaxoSmithKline PLC in front of the Third Circuit Tuesday, with the plaintiffs arguing that their suit against the pharmaceutical giant belongs in Pennsylvania state court.

But Glaxo responded with the claim that “settled and bright-line rules” for establishing corporate citizenship justify a federal court's decision not to remand the suit, filed in 2011 by Glenda Johnson and Steven Lucier, to Pennsylvania.

The plaintiffs claimed the suit belongs in Pennsylvania state...
To view the full article, register now.